Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma.
about
Multicenter Comparison of Contrast-Enhanced FDG PET/CT and 64-Slice Multi-Detector-Row CT for Initial Staging and Response Evaluation at the End of Treatment in Patients With LymphomaMy treatment approach to patients with diffuse large B-cell lymphoma.Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and CaveatsPositron Emission Tomography (PET) in Oncology18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell LymphomaPositron emission tomographic scans in lymphoma: convention and controversy.Primary lymphoma of the head and neck: two case reports and review of the literatureState-of-the-Art Research on "Lymphomas: Role of Molecular Imaging for Staging, Prognostic Evaluation, and Treatment Response".Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.Is there any additional benefit of contrast-enhanced CT as part of routine PET/CT protocols for the differentiation of suspicious incidental gastrointestinal 2-deoxy-(18)F-FDG uptake?Utility of baseline, interim and end-of-treatment 18F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase.FDG-PET imaging in hematological malignanciesImpact of FDG-PET/CT in the management of lymphoma.Advances in oncologic imaging: update on 5 common cancers.Current status of PET/CT in the diagnosis and follow up of lymphomas.Managing newly diagnosed follicular lymphoma: state of the art and future perspectives.When should FDG-PET be used in the modern management of lymphoma?Current role of FDG PET/CT in lymphoma.Role of PET in lymphoma.PET-CT in Staging, Response Evaluation, and Surveillance of Lymphoma.Imaging of primary pediatric lymphoma of bone.Role of multimodality imaging in the diagnosis of lymphoproliferative malignancies and hematologic disorders of the kidneys.Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions.PET/CT: Current status in India.The role of FDG-PET in Hodgkin lymphomaPrimary gastrointestinal lymphoma.Radiation dose reduction through combining positron emission tomography/computed tomography (PET/CT) and diagnostic CT in children and young adults with lymphoma.PET/CT in the Evaluation of Relapsed or Refractory Hodgkin Lymphoma.Fluorodeoxyglucose positron emission tomography/computed tomography for evaluation of bone marrow involvement in lymphoma: when is it superior to biopsy?
P2860
Q30491972-053EEB38-CDCC-48DB-A6C2-EEE819609C90Q34251964-E61CF7B8-2DF8-4EB0-AE55-35436CD8F803Q34475763-4008454F-67E4-4D63-B4DC-322543E8E7F7Q34774840-FBD94C77-D22E-4BD7-8BBF-F14EA1E7DA9EQ35855599-69CAA352-C56F-4A3C-9BBB-6B4617F9E4FEQ36399538-1304218B-5AC0-4B78-9DAF-ACD7D97D1C06Q37090937-9A526B2B-04EC-4863-9B6B-CACF571D6E84Q37144956-771DA42D-CCDA-4D0B-A943-0B8131191463Q37240835-0AE82447-0561-4EBF-9FB1-C067968997B3Q37330019-EB39D7B0-59BB-4542-89B5-7340CEDCCA87Q37602246-6AC336FD-6C67-4458-B268-02C8E730DC31Q37632114-A00B3B2C-651C-424B-8A7E-E1EC87DB73A9Q37950857-4B68ED9B-59A9-469C-B7E1-E56A9CE02EA4Q38052458-79A22209-31E1-4D44-A45B-88C3558B76D7Q38071295-540C9B9C-2D7E-4E6E-908D-1A1530B6685AQ38088002-001D0326-F230-4095-ABA8-B6C433496FDCQ38153086-29E355AC-F0B1-40BB-B09E-2EFF0F90640FQ38187365-25694E1D-D092-466C-A476-92EA8DF95FC3Q38195220-65EAC7FE-2C72-4ED3-A39F-24D06A5E4D80Q38794783-BBCD677C-ED47-4863-9E8F-99FC4D832B55Q38797810-51E6A59E-6901-4093-B436-6BCFABC3B1D1Q38930330-18FAC538-3559-4358-8D93-4EBF170B2C1DQ39737595-CED42E2A-AA87-4722-87F6-FF9C40E561BFQ39944862-88F8F8EE-949E-4221-83E6-3A19AB361E60Q41691698-47A2E758-5F63-4ABE-B4A2-FF5D0A7268C5Q42010612-9EB0C67A-9AD4-485E-A9CD-B9DC67B65D36Q47696231-E214B5A2-9C60-443C-9B82-2C94ED6DF932Q49764261-C29DB08C-F492-4151-AF00-26F9C1143B2BQ53198724-7F23479A-4CFB-4D36-AB30-3410C421F9B4
P2860
Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combined PET and low-dose, non ...... ing or restaging for lymphoma.
@en
Combined PET and low-dose, non ...... ing or restaging for lymphoma.
@nl
type
label
Combined PET and low-dose, non ...... ing or restaging for lymphoma.
@en
Combined PET and low-dose, non ...... ing or restaging for lymphoma.
@nl
prefLabel
Combined PET and low-dose, non ...... ing or restaging for lymphoma.
@en
Combined PET and low-dose, non ...... ing or restaging for lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
Combined PET and low-dose, non ...... ing or restaging for lymphoma.
@en
P2093
J P Leonard
R K J Brown
R L Elstrom
P2860
P304
P356
10.1093/ANNONC/MDN282
P577
2008-06-10T00:00:00Z